anxiety

shutterstock_177126911

Introduction

Anxiety is something we can all relate to. For the most part, anxiety represents a healthy and adaptive physiological response to feared stimuli, preparing your body to respond accordingly. Perfect if you a™re being chased by a bear. However, it can be problematic if those feared stimuli are benign, no longer present, or constitute persistent worries about the future.

At it™s most debilitating, anxiety can be classified into a range of psychiatric diagnoses. The most common of these is generalised anxiety disorder (GAD), which has an estimated lifetime prevalence in the UK of between 4-7%. GAD is characterised by a range of physical symptoms such as muscle tension, poor concentration and disturbed sleep, as well as psychological symptoms such as ongoing and uncontrollable worry. Diagnoses such as panic disorder, social anxiety disorder and phobias all feature anxiety as a primary symptom. In total, anxiety-related difficulties have been estimated to affect as many as 18% of a US-based adult population over a 12-month period.

Though previously categorised as anxiety disorders, both obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are increasingly being understood as separate diagnoses, but again with anxiety as a common symptom.

What we know already

People with long-term physical health conditions are more prone to experience anxiety as a result. For example, it is estimated that people with Chronic Obstructive Pulmonary Disease (COPD) are up to 10 times more likely to receive a diagnosis of panic disorder than the general population. This, in turn, has considerable implications on healthcare expenditure.

Psychological treatments such a cognitive-behavioural therapy (CBT) have been widely researched and shown to be effective across a range of anxiety disorders. In the case of specific phobias, these techniques can elicit significant improvement in just one session. However, improvement rates are lower across other anxiety disorders.

In England, the National Institute for Health and Care Excellence (NICE) recommends CBT as the first line treatment of anxiety disorders. Pharmacotherapy, such as Sertraline, can also be beneficial, and is recommended as an adjunct to CBT where the person’™s difficulties are more severe.

Areas of uncertainty

Anxiety has been conceptualised in many ways, which in many ways have shaped the range of treatments available. This proliferation of cognitive, developmental, information-processing, neurochemical and other models of understanding anxiety can create a confusing picture. Similarly, whilst there is a clear hereditary component to anxiety, the precise nature is not yet clear.

Whilst psychological and pharmacological treatments can be effective for many, there is still work to be done in identifying the mechanisms of change and improving outcomes.

What’s in the pipeline?

Historically, research into anxiety disorders focused more heavily on adult populations. However, with the recent emergence of disciplines such as paediatric psychology, there is a greater emphasis on tackling anxiety difficulties at a younger age.

As our understanding of genetics improves, it is likely that we will discover more about the role of heritability in anxiety.

Perhaps, most importantly, given the effectiveness of treatments for anxiety, we should aim to reduce stigma and other barriers to access, to enable earlier intervention and better recovery.

References

Antony, M. M., and Stein, M. B. (2009). Oxford handbook of anxiety and related disorders. Oxford University Press. [Publisher]

Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012). Generalized anxiety disorder: diagnosis and treatment. BMJ, 345. [Abstract]

Kesller, R. C., Ciu, W. T., Deler, O. and Walters, E. E. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [PDF]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our anxiety Blogs

Antidepressant discontinuation and continuation: new Cochrane review finds miasma of confound

Depression.,Antidepressants.,Young,Character,Trapped,In,A,Pill,Bottle.,Capsules.

Adele Framer, Founder of SurvivingAntidepressants.org, explores a recent Cochrane review on antidepressant discontinuation versus continuation for adults with depression or anxiety, which highlights huge uncertainty in the science about antidepressant withdrawal.

[read the full story...]

Mental health difficulties commonly reported by ICU staff during the pandemic

vladimir-fedotov-YLmPK-XA1cM-unsplash

Nada Seif reviews a recent survey study on self-reported mental health problems in ICU staff working during the UK 2020 COVID-19 pandemic.

[read the full story...]

Living in anxious times? The rise of anxiety disorders in the UK

Close,Up,Frustrated,Thoughtful,Young,Woman,Thinking,About,Problems,,Sitting

Alice Grishkov and Derek Tracy explore a recent paper, which finds that generalised anxiety disorder is on the rise in the UK, especially in young women.

[read the full story...]

Parental presence and children’s dental anxiety

shutterstock_54042145 - Child, dentists & X-ray

This review of whether parents’ presence in the room influences children’s behaviour, anxiety and fear during dental treatment included 16 studies. The findings suggest that parents’ presence in the operation room does not influence children’s (up to 12 years old) behaviour, anxiety and fear during dental treatment. However the included studies are all at high risk of bias so the certainty of the evidence is very low.

[read the full story...]

Dental Fear in Adults

shutterstock_110356511

This review aiming to estimate the global prevalence of dental fear in adults included 31 observational studies the majority of which were at high risk of bias. The findings suggest an overal prevalence of 15.3 % (95%CI; 10.23 to 21.15%).

[read the full story...]

Are apps for depression and anxiety worth the money?

Featured

Andres Fonseca summarises a recent RCT which finds that apps for depression and anxiety in an IAPT service can be effective and cost effective.

[read the full story...]

Mental health apps: using implementation science to understand sustained use

Featured

Bethany Gill summarises a recent narrative review of mental health apps for depression and anxiety, which explores what’s needed to make sure apps are successfully implemented and used sustainably.

[read the full story...]

‘Chin up, love.’ Why are frail older adults not seeking help for anxiety or depression?

matthew-bennett-78hTqvjYMS4-unsplash

A group of students from the UCL MSc in Mental Health Studies summarise a qualitative study on supporting frail older adults with anxiety or depression.

[read the full story...]

How has the COVID-19 lockdown affected our mental health?

glen-carrie-9w0J-XVx8vU-unsplash

Marco Solmi and Samuele Cortese review a recent longitudinal study exploring the trajectories of anxiety and depression during the COVID-19 lockdown in England.

[read the full story...]

Revenge porn and social anxiety: how can we help victims? #SaferInternetDay

Featured

In her debut blog, Katie Masters summarises recent qualitative research, which finds that victims of ‘revenge porn’ can experience symptoms of social anxiety.

[read the full story...]